2024-09-16 - Analysis Report
## PDD Stock Analysis Report

**Company:**  **PPD, Inc.** (Pharmaceutical Product Development, LLC) is a global contract research organization (CRO) that provides comprehensive drug development services to pharmaceutical, biotechnology, and medical device companies.

**Performance vs. S&P 500 (VOO):**

* **Cumulative Return:** 251.2% (PDD) vs. 88.73% (VOO)
* **Relative Strength:**  PDD has significantly outperformed VOO, with a 162.47% difference in cumulative returns. This places PDD at the 31.06 percentile of its historical performance range compared to VOO.

**Recent Price Movement:**

* **Closing Price:** $94.99
* **5-day Moving Average:** $94.62
* **20-day Moving Average:** $110.09
* **60-day Moving Average:** $126.90

**Technical Indicators:**

* **RSI:** 19.27 (Suggests the stock is oversold, potentially indicating a potential rebound)
* **PPO:** -0.57 (Negative value signifies a bearish signal, indicating potential downward momentum)
* **Delta_Previous_Relative_Divergence:** -20.57 (Negative value indicates a recent decline in relative strength compared to previous performance)
* **Expected Return:** 418.88% (Represents the maximum expected return over 5 years based on the current investment amount)

**Recent Earnings and Outlook:**

| Date | EPS | Expected EPS |
|---|---|---|
| 2024-08-26 | 3.2 | 2.89 |
| 2024-05-22 | 2.83 | 1.6 |
| 2024-03-20 | 2.4 | 1.59 |
| 2023-11-28 | 1.55 | 1.23 |
| 2023-08-29 | 1.44 | 1.12 |

**Analysis:**

* **Strong Outperformance:**  PDD has consistently outperformed the S&P 500, indicating strong growth potential.
* **Potential Reversal:** Despite recent price decline, the oversold RSI suggests a potential bounce back.
* **Earnings Beat:**  PDD has consistently exceeded earnings expectations in recent quarters, showcasing strong financial performance.
* **Positive Outlook:**  The high expected return indicates a favorable outlook for potential investors.

**Overall:** PDD exhibits strong historical performance, a recent decline possibly setting up for a rebound. Strong earnings performance and high expected return suggest a positive outlook, making it a potential consideration for investors seeking growth opportunities. However, technical indicators and recent price movement warrant further analysis before making investment decisions.
